Viewing data from:

EPLERENONE

ANDA

EPLERENONE | A207842 | WESTMINSTER PHARMACEUTICALS LLC

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: INSPRA(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.4655

per ea

Lowest NADAC/Unit

$0.3092

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
69367030809EPLERENONE 50 MG TABLET	$0.4655	EA	Generic	—	2026-06-17
69367030830EPLERENONE 50 MG TABLET	$0.4655	EA	Generic	—	2026-06-17
69367030709EPLERENONE 25 MG TABLET	$0.3092	EA	Generic	—	2026-06-17
69367030730EPLERENONE 25 MG TABLET	$0.3092	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 6 NDCs (6 FSS)

Lowest Price

$10.24

Highest Price

$69.56

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
69367-0307-09EPLERENONE 25MG TAB	$43.04	FSS	AvKare, LLC	06/14/2028
69367-0307-30EPLERENONE 25MG TAB	$10.24	FSS	AvKare, LLC	06/14/2028
69367-0308-09EPLERENONE 50MG TAB	$69.56	FSS	AvKare, LLC	06/14/2028
69367-0308-30EPLERENONE 50MG TAB	$14.34	FSS	AvKare, LLC	06/14/2028
42291-0454-90EPLERENONE 25MG TAB	$45.78	FSS	AvKare, LLC	06/14/2028
42291-0455-90EPLERENONE 50MG TAB	$69.21	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain6 active DMFs1 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

INDUSTRIALE CHIMICA SRLEPLERENONE

DMF 197152006

MSN LABORATORIES PRIVATE LTDEPLERENONE [ROUTE CODE: PL]

DMF 234662010

AURISCO PHARMACEUTICAL CO LTDEPLERENONE

DMF 276722013

INDUSTRIALE CHIMICA SRLEPLERENONE PH. EUR.

DMF 329982018

HETERO LABS LTDEPLERENONE

DMF 338322019

ZHEJIANG SHENZHOU PHARMACEUTICAL CO LTDEPLERENONE API

DMF 370242022

APOTEX PHARMACHEM INCInactiveEPLERENONE MEK HEMISOLVATE (1:0.5)

DMF 197962006

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 25MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Oct 25, 2021

No patent or exclusivity listings for this strength.

#002 — 50MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Oct 25, 2021